Acute myeloid leukemia-driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias

Documenti analoghi

• Acute myeloid leukemia-driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias
  di: Dominic J. Fowler-Shorten, et al.
  Pubblicazione: (2024-01-01)
• P856: MULTIPLE MYELOMA DERIVED IL-6 REDUCES FATTY ACID METABOLISM IN THE LIVER BY DOWNREGULATING CD36 AND CPT1A IN HEPATOCYTES
  di: Martha Egheose Ehikioya, et al.
  Pubblicazione: (2023-08-01)
• P423: ACUTE MYELOID LEUKEMIA REPROGRAMS LIPID METABOLISM BY DOWNREGULATING CD36 EXPRESSION IN HEPATOCYTES.
  di: Rebecca Maynard, et al.
  Pubblicazione: (2023-08-01)
• P431: ACTIVATION OF MACROPHAGE STING ENHANCES PHAGOCYTOSIS OF ACUTE MYELOID LEUKAEMIA
  di: Rebecca Maynard, et al.
  Pubblicazione: (2023-08-01)
• Refractory Autoimmune Cytopenias Treated With Venetoclax
  di: Max J. Gordon, et al.
  Pubblicazione: (2019-06-01)